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Abstract
Background: Malaria incidence has been reported to be falling in several countries in sub-Saharan
Africa in recent years. This fall appears to have started before the widespread introduction of
insecticide-treated nets. In the new era of calls to eliminate and eradicate malaria in sub-Saharan
Africa, exploring possible causes for this fall seem pertinent.
Presentation of the hypothesis: The authors explore an argument that presumptive treatment
of fever cases as malaria may have pl ayed a rol e in reducing transmission of malaria by the
prophylactic effect of antimalarials and their widespread use. This strategy, which is already in
practise is termed Opportunistic Presumptive Treatment (OPT).
Testing the hypothesis: Further comparison of epidemiological indicators between areas with
OPT and more targeted treatment is required. If data suggest a benefit of OPT, combining long
acting antimalarials that have an anti-gametocyticidal activity component plus using high levels of
vector control measures may reduce transmission, prevent resistant strains spreading and be easily
implemented.
Implications of the hypothesis: OPT is practised widely by presumptive treatment of fever in
health facilities and home management of fever. Improving diagnosis using rapid diagnostic tests and
thus reducing the number of doses of antimalarials given may have counter intuitive effects on
transmission in the context of elimination of malaria in high to moderate transmission settings.
Background
There is an increasing body of evidence suggesting that the
burden of malaria in sub-Saharan Africa has been decreas-
ing over the past decade and continues to do so (see table
1) [1-7]. The causes of this decline are unclear yet with the
current calls for elimination and eradication of malaria[8]
the identification of factors causing this decrease, in par-
ticular those related to control strategies, would seem par-
amount.
To date the decrease in malaria transmission has been
documented in a number of countries including
Kenya[2], Tanzania[3,4], Mozambique[5], Swaziland[5],
South Africa[5], Guinea Bissau[6] and Eritrea[7]. The
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decrease in cases in Southern Africa coincides with indoor
residual spraying (IRS) programmes[5] but for the other
reports there is no single clear intervention that could
explain the declines. In Kenya it was noted that the decline
started before the widespread use of insecticide-treated
nets (ITNs)[2]. The decline appears to be broadly conti-
nent wide: there has been a reported decrease in the mean
prevalence of Plasmodium falciparum parasites in cross-sec-
tional surveys from 35% between 1985 and1999 to 20%
since 2000[1]. Thus, the decline in malaria predates scal-
ing-up of vector control measures including widespread
use of ITNs. During the 1980s and 90s the mainstay of
malaria control in Africa was presumptive treatment of
fever with an anti-malarial. This strategy has been pro-
moted by the Integrated Management of Childhood Ill-
ness (IMCI) and is adopted as policy in many developing
countries[9]. In places where transmission is low or
decreasing this strategy leads to over-diagnosis of malaria
cases[10].
Presentation of hypothesis
The commonest drugs used for presumptive treatment of
fever cases as malaria in the past 50 years of malaria con-
trol are chloroquine (CQ) and sulphadoxine-pyrimeth-
amine (SP). Both these drugs have a long half-life and
their efficacy and effectiveness for prophylaxis have been
clearly documented[11]. Thus, treating most febrile ill-
ness with antimalarials, practiced widely in sub-Saharan
Africa has lead to a mass and frequently applied treatment
against malaria that not only cleared parasitaemia in true
cases of malaria but also provided chemoprophylaxis for
three weeks in the case of CQ and four weeks in the case
of SP. We term this Opportunistic Presumptive Treatment
(OPT).
The mechanism of OPT is to effectively treat those who are
infected and prevent re-infection in both those who are
and in those who are not infected. As most infections
occur focally[12,13], correctly treating these individuals
clears active infection and prevents new infection in those
most at risk of malaria. This in turn reduces the parasite
burden in individuals and the infectious reservoir in the
community. In low incidence areas, depending on fre-
quency of treatment of fever as malaria, the community
may be receiving enough anti-malarial prophylaxis to
reduce transmission due to decreased carriage of parasites
and thus, cause a gradual decline in malaria burden.
Testing the hypothesis
The likelihood is that the fall in malaria is multi-factorial
with general economic development, climate change and
malaria control strategies playing roles and identifying the
role OPT has played is complex. However, as treatment of
all fever cases remains standard practice in many endemic
countries a longitudinal comparison of epidemiological
parameters between current practice (OPT) and more tar-
geted treatment of parasite positive febrile cases in the
context of other control methods (e.g.ITN) should be
undertaken. Strategies for evaluation could be (1) OPT
with an ACT or non-ACT for all fever cases without any
other obvious cause (current practice); (2) OPT plus an
antibiotic for all fever cases; (3) ACT for confirmed cases
Table 1: Summary of studies describing reduction in malaria in sub-Saharan Africa
Country
/regionreference
Years of 
study
Measure of
reduction
Reported
reduction
Reported
Reasons 
Sub-Saharan Africa1 1985 to 1999; 2000 to 
2007
Parasite prevalence 
abstracted from over 2,000 
sources
15% (average) reduction No reason given
Coastal Kenya2 1999 to 2007 Malaria specific hospital 
admissions
63%, 53% and 28% 
reduction in 3 district 
hospitals
Malaria control 
interventions
Ifakara, Tanzania3 1995 to 2000 Incidence of malaria in < 5 
year old children
Reduced from 0.8 to 0.43 
episodes per child per year
Economic improvements, 
liberalisation of health 
sector and malaria control 
interventions
Zanzibar, Tanzania4 2003 to 2006 Parasite prevalence 97% reduction Artemisinin Combination 
Therapy and Insecticide 
Treated Nets
Mozambique, South Africa 
and Swaziland5
2000–2004 Parasite prevalence > 60% fall in parasite 
prevalence in all 3 zones 
studied
Indoor residual spraying
Guinea-Bissau6 1994 versus 2003/2004 Parasite prevalence Reduced from 44–79% to 
3%
Untreated bed nets and 
urbanisation
Eritrea7 2000 to 2004 Incidence of clinical malaria 
and case fatality rate 
reported by health facilities
Decrease in malaria 
incidence of 83.3% and case 
fatality by from 0.21 to 
0.14%
Climate change and malaria 
control methods (ITNs, IRS 
and early case detection 
and treatment)Malaria Journal 2008, 7:132 http://www.malariajournal.com/content/7/1/132
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of malaria (slide or rapid test positive) and OPT with non
ACT plus an antibiotic for fever cases confirmed negative
for malaria.
OPT has similarities to mass administration of antimalar-
ial drugs (MDA). MDA for limited time periods has been
tried for reducing transmission in the past without
marked or sustained success[14]. However, OPT, given to
individuals at high risk of carrying parasites for several
years may have a different outcome than MDA. Since OPT
is given to individuals who have a febrile illness an arte-
mesinin in combination with a long-acting partner drug
such as amodiaquine, mefloquine or piperiquine could
be used. Artemesinins would act to reduce gametocyte car-
riage[15] while the long-acting partner drug would pre-
vent new blood stage infections and thus new gametocyte
production. Alternatively, non-ACTs using a combination
of long acting drugs maybe preferred, thus saving the arte-
mesinin component for treatment of proven disease, and
these could be combined with gametocidal drugs such as
primaquine or tafenoquine.
Programmes using long-acting drugs are at risk of induc-
ing drug resistance. Both CQ and SP are no longer recom-
mended for treating clinical malaria in Africa due to high
levels of resistance. Combining long acting drugs and
using high levels of vector control measures to reduce
transmission of resistant strains may reduce the risk of
drug resistance. Studies to evaluate the impact of OPT in
combination with vector control measures on transmis-
sion of malaria, the emergence of drug resistance and cost-
effectiveness in Africa will be complex, large and expen-
sive, and will require several years of follow up time.
However, implementation of OPT would be relatively
easy as the delivery mechanism is largely in place and the
practise of presumptive treatment of fever is common
amongst health professionals and the community.
Implications of the hypothesis
Currently OPT is delivered through the routine health care
delivery system in most parts of Africa. Home manage-
ment of malaria[16] is an extension of OPT in the com-
munities. Due to pressures of over-diagnosis of malaria
which has adverse outcomes for patients[10] and misin-
forms malaria control programmes, introduction of rapid
diagnostic tests are being considered as a cost effective
measure to improve the accuracy of diagnosis of
malaria[17]. If the hypothesis is true, restricting antima-
larial treatment to confirmed cases of malaria only will
have little impact on control in high/moderate endemic
settings as fewer people will be exposed to prophylactic
levels of drugs. Treating fever cases confirmed as malaria
with ACT and as non malaria with non-ACT OPT plus an
antibiotic would circumvent this problem and have the
added advantage of broadening syndromic management
of fever to cover the most serious alternative diagnoses
(i.e. bacterial sepsis). However, any widespread use of
drugs will result in the community being exposed to drugs
and their associated problems of side effects and drug
resistance.
As transmission decreases there will be a point at which
there is no benefit to be gained from treating asympto-
matic carriers and preventing infection by prophylaxis.
The level of transmission where changing strategies
becomes advantageous is not known. However, when this
point is reached active case detection and treatment plus
surveillance for outbreaks would be the control method of
choice.
Malaria remains a huge public health issue that needs the
full armoury of current interventions. The good news is
that, for whatever reason, malaria seems to be decreasing
in many parts of sub-Saharan Africa. The recent call for
eradication of malaria is timely and to achieve this aim all
effective interventions need to be scaled up. In areas of
moderate to high transmission mass over-treatment of
fever as malaria (OPT) should be investigated as tool for
malaria control. The major risk of this strategy is increas-
ing drug resistance but the benefits may be much reduced
malaria as is evident in parts of Africa.
Authors' contributions
All authors discussed and reviewed the ideas presented in
the paper. All authors wrote the paper and read and
approved the final version.
Acknowledgements
We thank Colin Sutherland for his insightful comments on the manuscript 
and the reviewers who improved the work. The work involved stimulating 
discussions with many people including Professor Chris Curtis who sadly 
passed away, Caroline Maxwell, Kevin Marsh, Brian Greenwood, Lorenz 
von Seidlein, Michala Vaaben Rose, Dr Samwel Gesase, Cally Roper and 
Azra Ghani to name but a few. RG is funded by the Bill and Melinda Gates 
Foundation, CD is funded by the Wellcome Trust, AM is funded by the 
Government of Tanzania and DC is funded by the London School of 
Hygiene and Tropical Medicine. All authors state no conflict of interest.
References
1. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI,
Snow RW: The limits and intensity of Plasmodium falciparum
transmission: implications for malaria control and elimina-
tion worldwide.  PLoS Med 2008, 5(2):e38.
2. Okiro E, Hay SI, Gikandi PW, Sharif SK, Noor A, Peshu N, Marsh K,
Snow RW: The decline in paediatric malaria admissions on
the coast of Kenya.  Malaria Journal 2007, 6(151):. doi:10.1186/
1475-2875-1186-1151.
3. Schellenberg D, Menendez C, Aponte J, Guinovart C, Mshinda H, Tan-
ner M, Alonso P: The changing epideimology of malaria in
Ifakara Town, Southern Tanzania.  Tropical Medicine and Interna-
tional Health 2004, 9(1):68-76.
4. Bhattarai A, Ali AS, Kachur P, Martensson A, Abbas AK, Khatib R, Al-
mafazy A, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla
S, Montgomery SM, Kaneko A, Bjorkman A: Impact of artemesi-
nin- based combination therapy and insecticide- treated nets
on malaria burden in Zanzibar.  Plos Medicine 2007, 4(11):e309.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2008, 7:132 http://www.malariajournal.com/content/7/1/132
Page 4 of 4
(page number not for citation purposes)
5. Sharp B, Kleinschmidt I, Streat E, Maharaj R, Barnes K, Durrheim DN,
Ridl FC, Morris N, Seocharan I, Kunene S, La Grange JJP, Mthembu
JD, Maartens F, Martin CL, Barreto A: Seven years of regional
malaria control colaboration- Mozambique, South Africa
and Swaziland.  Am J Trop Med Hyg 2007, 76(1):42-47.
6. Rodrigues A, Armstrong Schellenberg J, Kofoed PE, Aaby P, Green-
wood B: Changing pattern of malaria in Bissau, Guinea Bis-
sau.  Trop Med Int Health 2008, 13(3):410-417.
7. Nyarango PM, Gebremeskel T, Mebrahtu G, Mufunda J, Abdulmumini
U, Ogbamariam A, Kosia A, Gebremichael A, Gunawardena D, Ghe-
brat Y, Okbaldet Y: A steep decline of malaria morbidity and
mortality trends in Eritrea between 2000 and 2004: the
effect of combination of control methods.  Malar J 2006, 5:33.
8. Roberts L, Enserink M: Did they really say ... Eradication.  Science
2007, 318:1545-1546.
9. Integrated Management of Childhood Illness (IMCI)   [http://
www.who.int/child_adolescent_health/topics/prevention_care/child/
imci/en/]
10. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E,
Mwerinde O, Saganda K, Shao J, Kitua A, Olomi R, Greenwood B,
Whitty CJM: Overdiagnosis of malaria inpatients with severe
febrile illness in Tanzania: a prospective study.  BMJ 2004,
329:1212.
11. Winstanley P, Ward S: Malaria chemotherapy.  Adv Parasitol 2006,
61:47-76.
12. Yazoume Y, Kyotbutungi C, Louis VR, Sauerborn R: Micro-epidemi-
ology of Plasmodium falciparum malaria: Is there any differ-
ence in transmission risk between neighbouring villages?
Malar J 2007, 6(46):. doi: 10.11 86/1475-2875-1476-1446.
13. Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh
K: Evidence for over-dispersion in the distribution of clinical
malaria episodes in children.  PLoS ONE 2008, 3(5):e2196.
14. von Seidlein L, Greenwood BM: Mass administrations of antima-
larial drugs.  Trends Parasitol 2003, 19(10):452-460.
15. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chong-
suphajaisiddhi T, White NJ: Effects of artemisinin derivatives on
malaria transmissibility.  Lancet 1996, 347(9016):1654-1658.
16. Hopkins H, Talisuna A, Whitty CJ, Staedke SG: Impact of home-
based management of malaria on health outcomes in Africa:
a systematic review of the evidence.  Malar J 2007, 6:134.
17. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills
A: Cost-effectiveness of malaria diagnostic methods in sub-
Saharan Africa in an era of combination therapy.  Bull World
Health Organ 2008, 86(2):101-110.